Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

The Global Fetal Monitoring Devices Market to Register Immense Growth at CAGR of ~7% by 2027 | DelveInsight

Published

on

New York, USA, Jan. 17, 2023 (GLOBE NEWSWIRE) — The Global Fetal Monitoring Devices Market to Register Immense Growth at CAGR of ~7% by 2027 | DelveInsight

The global fetal monitoring device market is anticipated to grow positively owing to the increased need for monitoring fetuses for various congenital disabilities and the prevalence of preterm births and post-term pregnancy, the development of technologically advanced fetal monitors, the growing adoption of minimally invasive procedures, and the rise in government and non-government initiatives for maternal and fetal health around the world.

DelveInsight’s Fetal Monitoring Devices Market Insights report provides the current and forecast market analysis, individual leading Fetal Monitoring Devices companies’ market shares, challenges, fetal monitoring devices market drivers, barriers, and trends, and key fetal monitoring devices companies in the market.

Key Takeaways from the Fetal Monitoring Devices Market Report

  • As per DelveInsight estimates, North America is anticipated to dominate the global fetal monitoring devices market during the forecast period. 
  • Notable fetal monitoring devices companies such as Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet, and several others are currently operating in the fetal monitoring devices market.
  • In March 2022, Butterfly Network, Inc., a digital health company transforming care with handheld, whole-body ultrasound, received a USD 5 million grant from the Bill and Melinda Gates Foundation to improve maternal and fetal health. With this grant, Butterfly will provide 1,000 healthcare workers in Sub-Saharan Africa with the Butterfly iQ+, the world’s only handheld, whole-body point-of-care ultrasound probe.
  • In February 2022, CooperSurgical set to acquire Cook Medical’s Reproductive Health Division to expand its offerings of ob-gyn and fertility medical devices. 
  • In June 2021, Remote pregnancy monitoring company Nuvo Group announced the FDA supplemental 510(k) clearance to add a new uterine activity module to its INVU system. INVU is a physician-prescribed, wearable pregnancy monitoring system.

To read more about the latest highlights related to the fetal monitoring devices market, get a snapshot of the key highlights entailed in the Global Fetal Monitoring Devices Market Report

Fetal Monitoring Devices Overview

A fetal monitoring device is a medical device that includes a monitoring unit, cables, and electrodes. They are intended to measure, record, and display fetal heart rate, uterine contractions, and maternal blood pressure, as well as heart rate, before and during childbirth. It is a medical method used to check the health of an unborn baby to ensure a safe birth. Furthermore, it tracks chronic lung diseases, mental retardation, neonatal diseases, hypothermia, vision and hearing problems, and jaundice.

Fetal Monitoring Devices Market Insights

North America is expected to account for the largest share of the global fetal monitoring devices market out of all regions. Factors such as the increasing prevalence of various fetal birth defects and an increase in preterm births are expected to aid in the growth of the North American fetal monitoring devices Market. Furthermore, the country’s government is actively involved in maternal and fetal health initiatives throughout the country. According to the CDC 2022, several state-based birth defects programs currently track CHDs in newborns and young children. As a result of the rising prevalence of these defects in the country, there will be greater demand for treatments that use fetal monitoring devices, creating a favorable growth environment for the United States fetal monitoring devices market and the North American region.

To know more about why North America is leading the market growth in the fetal monitoring devices market, get a snapshot of the Fetal Monitoring Devices Market Outlook 

Fetal Monitoring Devices Market Dynamics

The fetal monitoring devices market is experiencing increased product demand for a variety of reasons. The primary driver of product demand is an increased need to monitor fetuses for various birth defects. Furthermore, the prevalence of preterm births, post-term pregnancy, the development of technologically advanced fetal monitors, the growing adoption of minimally invasive procedures, and the increase in government and non-government initiatives for maternal and fetal health across the world are anticipated to bolster the fetal monitoring devices market growth.

However, the risks associated with invasive fetal monitoring and the high equipment cost may be some of the factors limiting the growth of the fetal monitoring devices market.

Additionally, the fetal monitoring devices market witnessed a COVID-19 outbreak, which significantly increased the use of fetal monitoring devices. People who had COVID-19 during their pregnancy were at an increased risk of complications affecting their pregnancy and developing babies. COVID-19, for example, increases the risk of having a preterm (before 37 weeks) or stillborn baby. This resulted in an increase in demand for fetal monitoring devices during the pandemic. Furthermore, the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape post pandemically made the resumption of regular healthcare services, which will keep demand for these products on track in the fetal monitoring devices market.

Get a sneak peek at the fetal monitoring devices market dynamics @ Fetal Monitoring Devices Market Dynamics Analysis

Report Metrics Details
Coverage Global
Study Period 2019–2027
Base Year 2021
Fetal Monitoring Devices Market CAGR ~7%
Projected Fetal Monitoring Devices Market Size by 2027 USD 4.72 Billion
Key Fetal Monitoring Devices Companies Koninklijke Philips N.V., General Electric Company, Cardinal Health, Nidek Medical, Siemens Healthcare GmbH, Heal Force, Medgyn Products, Inc., Promed Technology Co., Limited, Shenzhen Comen Medical Instruments Co., Ltd., Narang Medical Limited, Trivitron Healthcare, Neoventa Medical AB, Huntleigh Healthcare Ltd, EDAN Instruments, Inc., Shenzhen Bestman Instrument Co., Ltd., Natus Medical Incorporated, CooperSurgical Inc., Contec Medical Systems Co., Ltd, Life Plus Healthcare (P) Ltd., Bionet, among others

Fetal Monitoring Devices Market Assessment

  • Fetal Monitoring Devices Market Segmentation
    • Market Segmentation By Product: Ultrasound Devices (2D Ultrasound, 3D & 4D Ultrasound), Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Telemetry Devices, Others
    • Market Segmentation By Method: Invasive, Non-Invasive, 
    • Market Segmentation By Portability: Portable, Non-Portable
    • Market Segmentation By End User: Hospitals, Obstetrics & Gynecology Clinics, Others
    • Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
  • Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View

Which MedTech key players in the fetal monitoring devices market are set to emerge as the trendsetter explore @ Fetal Monitoring Devices Companies 

Table of Contents 

1 Report Introduction
2 Executive summary
3 Regulatory and Patent Analysis
4 Key Factors Analysis
5 Porter’s Five Forces Analysis
6 COVID-19 Impact Analysis on Fetal Monitoring Devices Market
7 Fetal Monitoring Devices Market Layout
8 Global Company Share Analysis – Key 3-5 Companies
9 Fetal Monitoring Devices Market Company and Product Profiles
10 Project Approach
11 About DelveInsight

Interested in knowing the fetal monitoring devices market by 2027? Click to get a snapshot of the Fetal Monitoring Devices Market Trends

Related Reports

Fetal and Neonatal Monitoring Devices Market

Fetal and Neonatal Monitoring Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key fetal and neonatal monitoring devices companies, including GE Healthcare, Medtronic, Siemens Healthcare, among others.

Beating Heart Stabilizers Market

Beating Heart Stabilizers Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key beating heart stabilizers companies, including Medtronic, Getinge AB, Terumo Cardiovascular Systems Inc, Chase Medical, among others.

Congestive Heart Failure (CHF) Treatment Devices Market

Congestive Heart Failure (CHF) Treatment Devices Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key congestive heart failure (CHF) treatment devices companies, including General Electric Company, Boston Scientific Corporation, Medtronic, among others.

Prosthetic Heart Valve Market

Prosthetic Heart Valve Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key prosthetic heart valve companies, including Medtronic, Boston Scientific Corporation, St, Jude Medical, among others.

Tissue Heart Valves Market

Tissue Heart Valves Market Insight, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key tissue heart valves companies, including Abbott, Boston Scientific Corporation, CryoLife, Inc., Edward Lifesciences Corporation, Medtronic, among others.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Brain Cancer Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuroblastoma Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance.  


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting

Published

on

oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting

SAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 31 – June 4, 2024, in Chicago, Illinois. Details on the abstracts and poster presentation are shown below.

Title: Phase 1/2 randomized, open-label, multicenter, Simon two-stage study of pelareorep combined with modified FOLFIRINOX +/- atezolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
Presentation Type: PosterAbstract Number: TPS4203Session Title: Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and HepatobiliarySession Date and Time: June 1, 2024, 1:30 – 4:30 p.m. CTTitle: Pelareorep driven blood TIL expansion in patients with pancreatic, breast and colon cancer.Presentation Type: Online abstractAbstract Number: e14625
Abstracts will be published on the ASCO Annual Meeting website at 5:00 p.m. ET on May 23, 2024.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot” — through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid and hematological malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
 
Company Contact
Jon Patton
Director of IR & Communication
[email protected]
 
Investor Relations for Oncolytics
Timothy McCarthy
LifeSci Advisors
+1-917-679-9282
[email protected]
 
 

View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting-302127245.html

Continue Reading

Artificial Intelligence

Internet of Things (IoT) Market to Expand at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology

Published

on

internet-of-things-(iot)-market-to-expand-at-a-stellar-19.4%-cagr-through-2031-|-skyquest-technology

WESTFORD, Mass., April 25, 2024 /PRNewswire/ — SkyQuest projects that the Internet of Things (IoT) Market will attain a value of USD 1572.37 billion by 2031, with a CAGR of 19.4% over the forecast period (2024-2031). Internet of Things (IoT) refers to the network of connected devices over the internet that are embedded with sensors and software. Growing adoption of automation around the world and advancements in connected device technologies are forecasted to be key factors driving the Internet of Things (IoT) market growth in the future.

Download a detailed overview:
https://www.skyquestt.com/report/internet-of-things-market
Browse in-depth TOC on “Internet of Things (IoT) Market”
Pages – 197Tables – 69Figures – 75Internet of Things (IoT) Market Overview:
Report Coverage
Details
Market Revenue in 2023
$ 380.6 billion
Estimated Value by 2031
$1572.37 billion
Growth Rate
Poised to grow at a CAGR of 19.4%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Component Type, Application, and Region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Rising demand for connected healthcare and growing use of industrial automation solutions
Key Market Drivers
Advancements in connectivity and connected device technologies
 
 
Hardware is Estimated to Dominate the Global Market Share Owing to High Use of Hardware Components in IoT
Hardware components such as sensors and actuators are highly vital to the proper functioning of any kind of Internet of Things (IoT) device. Growing adoption of IoT devices in different industry verticals for various applications is promoting market growth via this segment. The development of new hardware solutions also helps this segment maintain its dominance.
Smart Agriculture is the Fastest-growing Segment Owing to Rising Adoption of Precision Agriculture Practice
Rising emphasis on improving agricultural yield and sustainability has resulted in the growing adoption of smart agriculture and precision agriculture practices. IoT devices play a crucial role in monitoring and controlling different elements of a smart agriculture setup that is mostly automated using different smart devices thereby contributing to the IoT market growth as well.
Growing Adoption of 5G Technology Allowing North America to Dominate the Global Internet of Things (IoT) Market
Rapid adoption of 5G technology and high use of cloud-based platforms are key factors allowing North America to lead the demand for Internet of Things (IoT) around the world. Surging investments in the research and development of advanced technologies and the presence of key tech giants such as Amazon, Google, IBM, and Microsoft also helps the dominance of this region. Canada and the United States remain the most lucrative markets for Internet of Things (IoT) companies in North America through 2031.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/internet-of-things-market
Internet of Things (IoT) Market Insights:
Drivers
Advancements in connectivity and connected device technologies.Growing demand for Industrial IoT (IIoT) solutions.Increasing number of smart cities and development of smart infrastructure.Restraints
Lack of standardization of IoT devices and technologies.Privacy and data security issues.Interoperability challenges and complex integration scenarios.Prominent Players in Internet of Things (IoT) Market
MicrosoftCisco SystemsIntelSiemens (Germany)AWS (US)Oracle (US)Qualcomm (UK)SAP (Germany)IBM (US)Google (US)View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/internet-of-things-market
Key Questions Answered in Internet of Things (IoT) Market Report
What are the top drivers for Internet of Things (IoT) market going forward?Who are the leading Internet of Things (IoT) market players?Where will demand for Internet of Things (IoT) be high?Which component accounts for a dominant revenue share of the global Internet of Things (IoT) market?This report provides the following insights:
Analysis of key drivers (advancements in connectivity and connected device technologies, growing demand for industrial IoT (IIoT), development of smart infrastructure for smart cities, growing use of smart devices ), restraints (lack of standardization, complexities in integration, concerns regarding security and privacy of data), and opportunities (rising popularity of connected healthcare, increasing adoption of Industry 4.0, rising use of industrial automation), influencing the growth of Internet of Things (IoT) market.Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the Internet of Things (IoT) market.Market Development: Detailed analysis of potential regions where the market has potential to grow.Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.Related Reports:
Global Internet of Things in Retail Market
Global Internet of Things (IoT) in Agriculture Market
Global Internet of Things (IoT) Microcontroller Market
Global IOT In Healthcare Market
Global IOT in Manufacturing Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific. 
Contact:
Mr. Jagraj Singh Skyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/

View original content:https://www.prnewswire.co.uk/news-releases/internet-of-things-iot-market-to-expand-at-a-stellar-19-4-cagr-through-2031–skyquest-technology-302127239.html

Continue Reading

Artificial Intelligence

Sapiens Unveils Enhanced Reinsurance and Analytics Solution Catering to Evolving Market Demands

Published

on

sapiens-unveils-enhanced-reinsurance-and-analytics-solution-catering-to-evolving-market-demands

Latest version enhances operational efficiency, regulatory reporting, and strategic decision-making with robust business insights
ROCHELLE PARK, N.J., April 25, 2024 /PRNewswire/ — Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the launch of its latest version of Sapiens ReinsuranceMaster.

The new release of Version 9 brings a multitude of enhancements and technology stack updates, designed to empower insurers and reinsurers with robust, enriched functionality to support business requirements. This includes automating global inter-company retrocession, facilitating U.S. NAIC statutory reporting (Schedule F), and real-time reinsurance allocation support (‘reinsurance as a service’).
The latest release offers a multitude of enhancements, with one of the standout features being the seamless integration of Sapiens Intelligence with Sapiens ReinsuranceMaster. This integration empowers users with advanced data capabilities and actionable insights through out-of-the-box reinsurance reports and analytics of the reinsurance portfolio’s performance.
In addition, the new release brings significant improvements to the user experience, with a revamped user interface, enhancements in processing performance through improvements and parallel processing mechanisms, improved scalability and operability. 
“With the growing significance of reinsurance in today’s volatile environment, our latest version of Sapiens ReinsuranceMaster with Sapiens Intelligence offers even greater value to insurers and reinsurers, catering to the ever-changing demands of this dynamic market,” said Roni Al-Dor, Sapiens President & CEO. “Leveraging the shared experience from our other products as well as requirements from our global client base, the solution is now very well-positioned to support global automation of complex reinsurance programs and provide management with insights into reinsurance performance as well as statutory reporting.”  
Sapiens ReinsuranceMaster is a comprehensive, single platform for large and multi-national reinsurance programs, providing full financial control and flexibility across all lines of business. The solution supports the entire range of reinsurance contracts, providing full support for all auditing requirements and a consolidated view of liabilities and risks, as well as helping prevent financial leakage.
Sapiens Intelligence, now a fully integrated component of Sapiens ReinsuranceMaster v.9, produces actionable insights to maximize the value of data and KPIs for smarter decision making, improving reinsurance business management.
About Sapiens  
Sapiens International Corporation (NASDAQ and TASE: SPNS) empowers the financial sector, with a focus on insurance, to transform and become digital, innovative, and agile. With more than 40 years of industry expertise, Sapiens’ cloud-based SaaS insurance platform offers pre-integrated, low-code capabilities across core, data, and digital domains to accelerate our customers’ digital transformation. Serving over 600 customers in more than 30 countries, Sapiens offers insurers across property and casualty, workers’ compensation, and life insurance markets the most comprehensive set of solutions, from core to complementary, including Reinsurance, Financial & Compliance, Data & Analytics, Digital, and Decision Management. For more information visit https://sapiens.com or follow us on LinkedIn  
Investor and Media Contact : Yaffa Cohen-Ifrah Sapiens Chief Marketing Officer and Head of Investor Relations Email: [email protected] 
Forward Looking Statements
Certain matters discussed in this press release that are incorporated herein and therein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words “anticipate,” “believe,” “estimate,” “expect,” “may,” “will,” “plan” and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to:  the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; the global macroeconomic environment, including headwinds caused by inflation, relatively high interest rates, potentially unfavorable currency exchange rate movements, and uncertain economic conditions, and their impact on our revenues, profitability and cash flows; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers’ systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the coronavirus epidemic,  and fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company.
While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading “Risk Factors” in our Annual Report on Form 20-F for the year ended December 31, 2023, to be filed in the near future, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.
 
Logo: http://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/sapiens-unveils-enhanced-reinsurance-and-analytics-solution-catering-to-evolving-market-demands-302127409.html

Continue Reading

Trending